Hepatoma cell proliferation

Hepatoma cell proliferation refers to the pathological expansion and division of hepatocellular carcinoma (HCC) cells, the primary form of liver cancer. This process is characterized by the loss of normal cell cycle control, leading to uncontrolled tumor growth and potential metastasis (Llovet et al., 2021, Nature Reviews Disease Primers). It is driven by the dysregulation of multiple signaling pathways, including the VEGFR, EGFR, and IGF-1R pathways, as well as intracellular cascades like PI3K/Akt/mTOR and MAPK/ERK (Dimri & Satyanarayana, 2020, International Journal of Molecular Sciences). While inhibiting hepatoma cell proliferation is a central goal of oncology, the term itself represents a phenotypic outcome rather than a single druggable molecular target. Therapeutic agents typically address this process by targeting specific enzymes or receptors involved in the signaling network that sustains hepatoma growth.

Other names

Hepatocellular carcinoma cell proliferationLiver cancer cell growthHCC proliferationHepatoma growth

Not applicable as this is a biological process/phenotype, not a discrete molecular entity.